Unbiased Stranded cDNA Library Production via Asymmetric Adapters

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for determining mRNA sequences suffer from sequence bias during exponential amplification and inefficiency in single-stranded ligation, limited applicability to certain RNA and DNA forms, and require a 5'-terminal CAP, making it challenging to obtain unbiased and efficient selection of stranded RNA sequences.

Innovation Solution

The use of specific polynucleotide adapters with random nucleotide sequences and tags allows for unbiased selection of RNA strands by forming complexes with RNA molecules, extending primers through reverse transcription, and attaching double-stranded polynucleotide adapters to generate cDNA libraries that represent particular RNA strands without bias.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If exponential amplification methods are used to amplify mRNA, then the quantity of mRNA is increased, but sequence bias is introduced in the relative levels of different mRNAs

Engineering Contradiction:
Improvequantity of mRNAVSAvoidsequence bias
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The patent extracts and eliminates the harmful exponential amplification step from the workflow. Instead of amplifying mRNA sequences, the method directly sequences the original mRNA molecules after converting them to cDNA, thereby avoiding the introduction of sequence bias while still obtaining sufficient signal for detection through direct sequencing of the converted products

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces cDNA as an intermediary substance between mRNA and sequencing. The mRNA is first converted to cDNA through reverse transcription, and then the cDNA is directly sequenced without exponential amplification. This intermediary conversion allows the original mRNA sequence information to be preserved and read directly, avoiding the bias introduced by amplification methods

Inventive Principle:
Principle #24Intermediary (Mediator)

2Device complexity

If single-stranded ligation is used to attach adapters, then the process is simplified, but ligation efficiency is reduced

Engineering Contradiction:
Improveligation process complexityVSAvoidligation efficiency
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The patent applies local quality by creating asymmetric adapter structures with distinct 5' and 3' ends that have different properties. The first adapter has a 5' end optimized for ligation to the cDNA, while the second adapter has a 3' end optimized for ligation. This localized optimization at each end of the adapter molecules enables efficient directional ligation while maintaining process simplicity

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs asymmetric adapter design where the first and second adapters have different structures and orientations. The first adapter is ligated to the 5' end of the cDNA with its 3' end overhanging, while the second adapter is ligated to the 3' end of the cDNA with its 5' end positioned for ligation. This asymmetric arrangement ensures efficient and directional ligation at each end, resolving the contradiction between simplicity and efficiency

Inventive Principle:
Principle #4Asymmetry

3Quantity of substance

If existing amplification methods are used, then mRNA can be amplified, but applicability is limited to certain forms of RNA and DNA and requires a 5'-terminal CAP

Engineering Contradiction:
ImprovemRNA amplificationVSAvoidapplicability to RNA and DNA forms
Core Design Contradiction:
Quantity of substanceVSAdaptability or versatility

Solution Approach 1:

The patent creates a universal adapter system that can ligate to various forms of nucleic acids (mRNA, cDNA, and other RNA/DNA forms) without requiring specific structural features like 5'-terminal CAP. The adapters are designed with flexible ligation sites that can accommodate different nucleic acid types, making the method broadly applicable across multiple molecular forms while maintaining the ability to generate sufficient sequencing signal without amplification

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the creation of cDNA libraries that provide an unbiased representation of RNA samples, reducing sequencing costs and improving the identification of antisense expression, thereby enhancing gene regulation insights and reducing sequencing errors.

Implementation Method 1

hybridizing a first primer to an RNA sample under conditions wherein a complex is formed between a 3' region of the first primer and an RNA molecule in the RNA sample

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

extending the first primer by reverse transcription or a comparable enzyme or method known in the art, thereby generating a complementary molecule (e.g. a cDNA molecule)

Methodology Applied
Scientific EffectReverse transcription:

Implementation Method 3

hybridizing a double stranded polynucleotide molecule including a second nucleotide sequence tag to the complementary molecule under conditions wherein: (i) a complex is formed between a 3' overhang of the double stranded polynucleotide molecule and a 3' region of the cDNA molecule

Methodology Applied
Scientific EffectHybridization:

Implementation Method 4

attaching the 5' end of the complementary second strand of the double stranded polynucleotide molecule to the 3' end of the cDNA molecule, thereby generating an unattached strand of the double stranded polynucleotide molecule

Methodology Applied
Scientific EffectLigation:

Data Source

PatentEP2970957B1Methods for producing stranded cdna libraries
Publication Date: 2019.04.24 ILLUMINA INC
  • EP2970957B1 patent drawingFigure 1A
  • EP2970957B1 patent drawingFigure 1B
  • EP2970957B1 patent drawingFigure 2A

AI summary

The present system provides novel methods and compositions for selecting a particular strand of RNA and/or producing a cDNA library that results in an unbiased representation of RNA in a sample.